AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15323595
Drug: Fluoxetine 40
RxNorm normalized name: fluoxetine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 40 mg/day
Trial: 1902159
Drug: Active nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active nitroglycerin patches (mean necessary effective patch dose: 125 sq cm, range 60 to 220 sq cm)
Trial: 27753201
Drug: Liraglutide (1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (1.8 mg/d) for 12 weeks
Trial: 27178766
Drug: Single testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single testosterone injection
Trial: 22147468
Drug: Inoculated silage
RxNorm normalized name: silane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inoculated silage (IN) with mixed bacterial culture (1.0 × 10(11) cfu/g Lactobacillus buchneri LN4017, 2.0 × 10(10) cfu/g Lactobacillus plantarum LP7109, 1.0 × 10(10) cfu/g Lactobacillus casei LC3200)
Trial: 17292954
Drug: Nabumetone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabumetone (2 g or 1 g for 11 patients)
Trial: 26018634
Drug: Meloxicam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam (15 mg)
Trial: 9621139
Drug: pH5 Eucerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pH5 Eucerin aftersun lotion with 10% hamamelis distillate
Trial: 9621139
Drug: Other lotions
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other lotions (vehicle and prior aftersun formulation)
Trial: 3280325
Drug: Oral vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral vancomycin plus colistin (V/C)
Trial: 15281530
Drug: Arginine vasopressin
RxNorm normalized name: 1-deamino-8-D-arginine vasopressin
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine vasopressin (AVP) infusion (4 U/h)
Trial: 15281530
Drug: Norepinephrine (NE)
DrugBank: Norepinephrine (DB00368)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norepinephrine (NE) infusion alone
Trial: 11951146
Drug: Delta(9)-THC (5.0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delta(9)-THC (5.0, 7.5 or 10.0 mg)
Trial: 2477096
Drug: 7.5% NaCl/Dextran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5% NaCl/Dextran 70 solution
Trial: 30617461
Drug: l-bupivacaine (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-bupivacaine (12.5 mg h−1) continuous wound infusion for 48 hours via a pre-sternal multiperforated catheter
Trial: 30617461
Drug: l-bupivacaine (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-bupivacaine (12.5 mg h−1) continuous wound infusion for 48 hours
Trial: 21250913
Drug: rHuEPOα therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPOα therapy (300 IU/kg/dose, 3 times/week, subcutaneously)
Trial: 21250913
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no rHuEPOα therapy)
Trial: 9595999
Drug: Femoral injection
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femoral injection of echo contrast medium
Trial: 9595999
Drug: Femoral injection
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femoral injection of echo contrast medium plus Valsalva maneuver
Trial: 9595999
Drug: Ante cubital
RxNorm normalized name: wood ant preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ante cubital injection of echo contrast medium
Trial: 9595999
Drug: Ante cubital
RxNorm normalized name: wood ant preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ante cubital injection of echo contrast medium plus Valsalva maneuver
Trial: 1761875
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam 7.5 mg
Trial: 3035166
Drug: Salt and
RxNorm normalized name: ZINC OXIDE 240 mg in 1 g TOPICAL STICK [Salt and Stone Outdoor Voices SPF 50]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salt and peroxide oral hygiene regimen
Trial: 2536410
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral hygiene methods
Trial: 27436543
Drug: 6.5-mm hydrophilic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.5-mm hydrophilic implants placed with osteotome sinus floor elevation (OSFE)
Trial: 27436543
Drug: Standard implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard implants placed with lateral sinus floor elevation
Trial: 27436543
Drug: Long implant
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long implant group
Trial: 23736112
Drug: Indapamide sustained-release
RxNorm normalized name: Indapamide
DrugBank: Indapamide (DB00808)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indapamide sustained-release 1.5mg
Trial: 15719741
Drug: Weitai capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weitai capsule (WTC), 4 capsules, 3 times a day for 3 months
Trial: 10510988
Drug: IV unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV unfractionated heparin (UFH) - loading dose: 5000 U IV; initial infusion, 1250‐1280 U/h
Trial: 7718899
Drug: CY‐TBI (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CY‐TBI (120 mg/kg of cyclophosphamide followed by total body irradiation)
Trial: 7718899
Drug: BU‐CY (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BU‐CY (16 mg/kg of busulfan followed by 120 mg/kg of cyclophosphamide)
Trial: 7718899
Drug: MoAb (anti‐interleukin‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MoAb (anti‐interleukin‐2 receptor monoclonal antibody)
Trial: 2391395
Drug: SCH 39304
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 39304 with antacid
Trial: 6792073
Drug: Parenteral diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral diet (1.5 g amino acid . kg‐1 . d‐1 and 7.6 g carbohydrate kg . d‐1)
Trial: 6792073
Drug: Increased carbohydrate
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased carbohydrate infusion (1.5 g amino acids . kg‐1 . d‐1 and 12 g carbohydrate . kg‐1 . d‐1)
Trial: 6792073
Drug: Two-fold amino
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-fold amino acid intake (3.0 g . kg‐1 . d‐1 and 7.6 g carbohydrates . kg‐1 . d‐1)
Trial: 31663981
Drug: 10-μg estradiol
RxNorm normalized name: estradiol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-μg estradiol (E2) softgel vaginal insert
Trial: 31663981
Drug: 25-μg estradiol
RxNorm normalized name: estradiol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25-μg estradiol (E2) softgel vaginal insert
Trial: 26170395
Drug: 4 repeated
RxNorm normalized name: Tricontanyl Povidone (4 Tricontanyl Branches/Repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 repeated doses of albendazole
Trial: 26170395
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of albendazole
Trial: 16289984
Drug: Physiogel cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiogel cream (control)
Trial: 15127991
Drug: Tapered Brånemark
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tapered Brånemark System Mark IV fixture (97 implants)
Trial: 15127991
Drug: Brånemark Standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brånemark Standard or Mark II implants (92 implants)
Trial: 15127991
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Mark IV and control implants)
Trial: 11038030
Drug: Once-weekly schedule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly schedule of 5-fluorouracil and L-folinic acid
Trial: 11038030
Drug: Four-weekly schedule
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-weekly schedule of 5-fluorouracil and L-folinic acid
Trial: 1356646
Drug: Atracurium (ATR)
DrugBank: Atracurium (DB13295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atracurium (ATR) - loading dose 0.25 mg.kg‐1, infusion at 5.0 micrograms.kg‐1.min‐1
Trial: 1356646
Drug: Vecuronium (VEC)
DrugBank: Vecuronium (DB01339)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vecuronium (VEC) - loading dose 0.05 mg.kg‐1, infusion at 1.0 microgram.kg‐1.min‐1
Trial: 3910768
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg administered 1 hour before a standardized breakfast
Trial: 3910768
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg administered together with a standardized breakfast
Trial: 3910768
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered for 2 weeks prior to captopril
Trial: 27537754
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g IV paracetamol
Trial: 27537754
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g oral paracetamol
Trial: 27537754
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g oral paracetamol
Trial: 22854666
Drug: 10 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 μg hepatitis B vaccine
Trial: 22854666
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose at year 23
Trial: 12622499
Drug: Tramadol 20
RxNorm normalized name: TRAMADOL 200MG (RYZOLT) SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 20 mg intravenous bolus via patient-controlled analgesia device
Trial: 12622499
Drug: Morphine 2
RxNorm normalized name: apomorphine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 2 mg intravenous bolus via patient-controlled analgesia device
Trial: 10676043
Drug: Raloxifene, specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene, specific dosage and duration not available
Trial: 7547044
Drug: Peritonsillar infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritonsillar infiltration with tenoxicam 5 mg in 8 ml of normal saline (4 ml per tonsil)
Trial: 1778925
Drug: Caffeine (CAF,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF, 9 mg/kg)
Trial: 6754118
Drug: Oral erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral erythromycin ethyl succinate (paediatric dosage)
Trial: 6754118
Drug: Topical 1%
RxNorm normalized name: fluoride topical 1% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 1% tetracycline ointment
Trial: 30572905
Drug: Levofloxacin (15-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (15-20 mg/kg daily for six months)
Trial: 27573335
Drug: Tablet computer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet computer with the Breathing Easier Support Toolkit (BEST)
Trial: 22213304
Drug: Vinorelbine (oral)
DrugBank: Vinorelbine (DB00361)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vinorelbine (oral) 60 mg/m² on days 1, 8, 15 every 4 weeks for 4 cycles (group A)
Trial: 22213304
Drug: Paclitaxel (intravenous)
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel (intravenous) 90 mg/m² for 1 h on days 1, 8, 15 every 4 weeks for a total of 4 cycles (group B)
Trial: 20145555
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration (WBV) training at 35 Hz for 5 minutes twice a week
Trial: 12106923
Drug: LDL-A group
RxNorm normalized name: meningococcal group A polysaccharide
DrugBank: Meningococcal polysaccharide vaccine group A (DB13889)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL-A group (medication + LDL-A, n = 11)
Trial: 12106923
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (medication only, n = 7)
Trial: 1858944
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline infusion (0.855 M, 0.06 ml.min‐1.kg‐1)
Trial: 1858944
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline infusion (0.154 M, 0.06 ml.min‐1.kg‐1)
Trial: 1858944
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline infusion (0.855 M)
Trial: 31174494
Drug: Mobile phone
RxNorm normalized name: Chamaemelum nobile extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile phone app-based cognitive behaviour training (CBT) for 6 weeks, with weekly theme modules including learning content and assignments.
Trial: 25152290
Drug: Coopdech bronchial
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coopdech bronchial blocker (group A)
Trial: 22873532
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa (maintenance therapy)
Trial: 21209539
Drug: Volume preload
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volume preload of 1000 ml of Ringer's lactate solution
Trial: 2691479
Drug: Amoxycillin/clavulanate (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin/clavulanate (1,000 mg amoxycillin + 250 mg clavulanate) tds
Trial: 2691479
Drug: Ciprofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (500 mg) bd
Trial: 6154334
Drug: Hypothermic cardioplegic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothermic cardioplegic solution (200-1000 ml) infused into the ascending aorta during cardiopulmonary bypass.
Trial: 31764793
Drug: Nebulized ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized ipratropium bromide (1 mg, 4 ml) for 15 minutes before bronchoscopy
Trial: 26946208
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no intraoral device or treatment)
Trial: 22714779
Drug: Topical (S)-ketamine
RxNorm normalized name: esketamine
DrugBank: Esketamine (DB11823)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Topical (S)-ketamine
Trial: 16225527
Drug: Transdermal oxybutynin
RxNorm normalized name: oxybutynin Transdermal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal oxybutynin (1.3, 2.6, and 3.9 mg/day)
Trial: 16225527
Drug: Transdermal oxybutynin
RxNorm normalized name: oxybutynin Transdermal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal oxybutynin (3.9 mg/day)
Trial: 16225527
Drug: Extended-release tolterodine
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release tolterodine (4 mg/day)
Trial: 10068415
Drug: Daily intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily intravenous infusion of 60 microg of prostaglandin E1 (alprostadil‐alpha‐cyclodextrine)
Trial: 10744344
Drug: rHuEPO (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO (all doses)
Trial: 1959538
Drug: rHuEPO (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO (doses greater than 25 units/kg)
Trial: 6955123
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instruction and practice in proper toothcleaning techniques
Trial: 29984430
Drug: Mystery shop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mystery shop intervention with monthly feedback to clerks and servers.
Trial: 12131931
Drug: Clonazepam 2
RxNorm normalized name: clonazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 2 mg/day for 6 weeks
Trial: 9924158
Drug: Heparin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin treatment to maintain activated clotting time of >300 seconds
Trial: 368535
Drug: ibuprofen 1600
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: ibuprofen 1600 mg daily
Trial: 368535
Drug: indomethacin 100
RxNorm normalized name: indomethacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indomethacin 100 mg daily
Trial: 368535
Drug: indomethacin and
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: indomethacin and ibuprofen
Trial: 27919222
Drug: Capsaicin 8%
RxNorm normalized name: CAPSAICIN 8% PATCH KIT,4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin 8% patch (30 min) plus SOC
Trial: 27919222
Drug: Capsaicin 8%
RxNorm normalized name: CAPSAICIN 8% PATCH KIT,4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin 8% patch (60 min) plus SOC
Trial: 21887594
Drug: Experimental diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental diet containing 600 g/kg DM of wheat middlings (WM)
Trial: 21887594
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet containing 400 g/kg DM of corn
Trial: 21034938
Drug: Second-look procedures
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second-look procedures (SLP) before completing chemotherapy
Trial: 21034938
Drug: Second-look procedures
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second-look procedures (SLP) during treatment
Trial: 21034938
Drug: No second-look
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No second-look procedures (SLP) during treatment
Trial: 19302083
Drug: Naltrexone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (25 mg daily for 3 days prior to quit date, then 50 mg daily for 8 weeks)
Trial: 16156143
Drug: Intracameral injection
RxNorm normalized name: bimatoprost
DrugBank: Bimatoprost (DB00905)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intracameral injection of 2% hydroxypropyl methylcellulose (HPMC) during trabeculectomy (group II; n = 15)
Trial: 16156143
Drug: Conventional trabeculectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional trabeculectomy without HPMC injection (group I; n = 15)
Trial: 8826928
Drug: Good steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Good steroid response
Trial: 8826928
Drug: T-ALL treatment
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: T-ALL treatment protocols (8303, 8503-8703, and '88)
Trial: 8826928
Drug: Poor in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poor in vivo steroid response
Trial: 8826928
Drug: Leukocyte level
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukocyte level count > 50 x 10^9/l
Trial: 2124962
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 1000 mg once daily
Trial: 2124962
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 250 mg four times daily
Trial: 2124962
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 500 mg twice daily
Trial: 16516602
Drug: Quinapril at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril at a target dose of 60 mg/day
Trial: 9050888
Drug: N-acetylcysteine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (oral administration)
Trial: 3056288
Drug: Preoperative radiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiotherapy (34.5 Gy, divided into 15 daily doses of 2.3 Gy each)
Trial: 26201299
Drug: Cabotegravir 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabotegravir 10 mg once a day
Trial: 26201299
Drug: Cabotegravir 30
RxNorm normalized name: cabotegravir 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabotegravir 30 mg once a day
Trial: 26201299
Drug: Cabotegravir 60
RxNorm normalized name: cabotegravir 600 MG per 3 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabotegravir 60 mg once a day
Trial: 26201299
Drug: Efavirenz 600
RxNorm normalized name: efavirenz 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efavirenz 600 mg once a day with dual NRTIs
Trial: 26201299
Drug: Cabotegravir (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabotegravir (all doses combined)
Trial: 23592605
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg ropivacaine + 5 µg sufentanil
Trial: 23592605
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg ropivacaine + 5 µg sufentanil